Prognostic impact of indoleamine 2,3-dioxygenase 1 (IDO1) mRNA expression on circulating tumour cells of patients with head and neck squamous cell carcinoma
Panagiota Economopoulou(National and Kapodistrian University of Athens), Amanda Psyrri(National and Kapodistrian University of Athens), Evangelos Giotakis(National and Kapodistrian University of Athens), George Koytsodontis(National and Kapodistrian University of Athens), Μaria Anastasiou(National and Kapodistrian University of Athens), Μαρία Γκοτζαμανίδου(National and Kapodistrian University of Athens), George Kavourakis(National and Kapodistrian University of Athens), Evi Lianidou(Athens State University), George Dimitriadis(National and Kapodistrian University of Athens), Ioannis Kotsantis(National and Kapodistrian University of Athens), Pavlos Maragoudakis(National and Kapodistrian University of Athens), Αreti Strati(National and Kapodistrian University of Athens), Elena Vagia(Northwestern University), Eleni Gagari(Andreas Sygros Hospital), Athina Kladi-Skandali(National and Kapodistrian University of Athens), Efthymios Kirodimos(National and Kapodistrian University of Athens), Eirini Maratou(Hellenic Center for Disease Control & Prevention)
Cited by 30
Related Papers
Avelumab plus standard-of-care chemoradiotherapy versus chemoradiotherapy alone in patients with locally advanced squamous cell carcinoma of the head and neck: a randomised, double-blind, placebo-controlled, multicentre, phase 3 trial
|The Lancet Oncology|2021|618
Studies of insulin resistance in patients with clinical and subclinical hypothyroidism
|European Journal of Endocrinology|2009|459
The Landscape of Targeted Therapies in TNBC
|Cancers|2020|448